274 related articles for article (PubMed ID: 21093259)
1. Synthesis and 11β hydroxysteroid dehydrogenase 1 inhibition of thiazolidine derivatives with an adamantyl group.
Kwon SW; Kang SK; Lee JH; Bok JH; Kim CH; Dal Rhee S; Jung WH; Kim HY; Bae MA; Song JS; Ha DC; Cheon HG; Kim KY; Ahn JH
Bioorg Med Chem Lett; 2011 Jan; 21(1):435-9. PubMed ID: 21093259
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of heterocycle containing adamantane 11beta-HSD1 inhibitors.
Yeh VS; Patel JR; Yong H; Kurukulasuriya R; Fung S; Monzon K; Chiou W; Wang J; Stolarik D; Imade H; Beno D; Brune M; Jacobson P; Sham H; Link JT
Bioorg Med Chem Lett; 2006 Oct; 16(20):5414-9. PubMed ID: 16899366
[TBL] [Abstract][Full Text] [Related]
3. Discovery of adamantyl ethanone derivatives as potent 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) inhibitors.
Su X; Pradaux-Caggiano F; Thomas MP; Szeto MW; Halem HA; Culler MD; Vicker N; Potter BV
ChemMedChem; 2010 Jul; 5(7):1026-44. PubMed ID: 20486152
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and structural activity relationship of 11beta-HSD1 inhibitors with novel adamantane replacements.
Yeh VS; Kurukulasuriya R; Madar D; Patel JR; Fung S; Monzon K; Chiou W; Wang J; Jacobson P; Sham HL; Link JT
Bioorg Med Chem Lett; 2006 Oct; 16(20):5408-13. PubMed ID: 16890427
[TBL] [Abstract][Full Text] [Related]
5. Discovery and biological evaluation of adamantyl amide 11beta-HSD1 inhibitors.
Webster SP; Ward P; Binnie M; Craigie E; McConnell KM; Sooy K; Vinter A; Seckl JR; Walker BR
Bioorg Med Chem Lett; 2007 May; 17(10):2838-43. PubMed ID: 17350260
[TBL] [Abstract][Full Text] [Related]
6. Discovery and structure-activity relationships of pentanedioic acid diamides as potent inhibitors of 11beta-hydroxysteroid dehydrogenase type I.
Roche D; Carniato D; Leriche C; Lepifre F; Christmann-Franck S; Graedler U; Charon C; Bozec S; Doare L; Schmidlin F; Lecomte M; Valeur E
Bioorg Med Chem Lett; 2009 May; 19(10):2674-8. PubMed ID: 19395260
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of novel 3-amino and 29-hydroxamic acid derivatives of glycyrrhetinic acid as selective 11β-hydroxysteroid dehydrogenase 2 inhibitors.
Stanetty C; Czollner L; Koller I; Shah P; Gaware R; Cunha TD; Odermatt A; Jordis U; Kosma P; Classen-Houben D
Bioorg Med Chem; 2010 Nov; 18(21):7522-41. PubMed ID: 20851614
[TBL] [Abstract][Full Text] [Related]
8. Discovery and metabolic stabilization of potent and selective 2-amino-N-(adamant-2-yl) acetamide 11beta-hydroxysteroid dehydrogenase type 1 inhibitors.
Rohde JJ; Pliushchev MA; Sorensen BK; Wodka D; Shuai Q; Wang J; Fung S; Monzon KM; Chiou WJ; Pan L; Deng X; Chovan LE; Ramaiya A; Mullally M; Henry RF; Stolarik DF; Imade HM; Marsh KC; Beno DW; Fey TA; Droz BA; Brune ME; Camp HS; Sham HL; Frevert EU; Jacobson PB; Link JT
J Med Chem; 2007 Jan; 50(1):149-64. PubMed ID: 17201418
[TBL] [Abstract][Full Text] [Related]
9. The development and SAR of pyrrolidine carboxamide 11beta-HSD1 inhibitors.
Cheng H; Hoffman J; Le P; Nair SK; Cripps S; Matthews J; Smith C; Yang M; Kupchinsky S; Dress K; Edwards M; Cole B; Walters E; Loh C; Ermolieff J; Fanjul A; Bhat GB; Herrera J; Pauly T; Hosea N; Paderes G; Rejto P
Bioorg Med Chem Lett; 2010 May; 20(9):2897-902. PubMed ID: 20363126
[TBL] [Abstract][Full Text] [Related]
10. Adamantyl triazoles as selective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1.
Olson S; Aster SD; Brown K; Carbin L; Graham DW; Hermanowski-Vosatka A; LeGrand CB; Mundt SS; Robbins MA; Schaeffer JM; Slossberg LH; Szymonifka MJ; Thieringer R; Wright SD; Balkovec JM
Bioorg Med Chem Lett; 2005 Oct; 15(19):4359-62. PubMed ID: 16039856
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of new glycyrrhetinic acid derived ring A azepanone, 29-urea and 29-hydroxamic acid derivatives as selective 11β-hydroxysteroid dehydrogenase 2 inhibitors.
Gaware R; Khunt R; Czollner L; Stanetty C; Da Cunha T; Kratschmar DV; Odermatt A; Kosma P; Jordis U; Classen-Houben D
Bioorg Med Chem; 2011 Mar; 19(6):1866-80. PubMed ID: 21376605
[TBL] [Abstract][Full Text] [Related]
12. Adamantane 11-beta-HSD-1 inhibitors: Application of an isocyanide multicomponent reaction.
Sorensen B; Rohde J; Wang J; Fung S; Monzon K; Chiou W; Pan L; Deng X; Stolarik D; Frevert EU; Jacobson P; Link JT
Bioorg Med Chem Lett; 2006 Dec; 16(23):5958-62. PubMed ID: 16996734
[TBL] [Abstract][Full Text] [Related]
13. Mono-carbonyl curcumin analogues as 11β-hydroxysteroid dehydrogenase 1 inhibitors.
Lin H; Hu GX; Guo J; Ge Y; Liang G; Lian QQ; Chu Y; Yuan X; Huang P; Ge RS
Bioorg Med Chem Lett; 2013 Aug; 23(15):4362-6. PubMed ID: 23800686
[TBL] [Abstract][Full Text] [Related]
14. 2-amino-1,3-thiazol-4(5H)-ones as potent and selective 11beta-hydroxysteroid dehydrogenase type 1 inhibitors: enzyme-ligand co-crystal structure and demonstration of pharmacodynamic effects in C57Bl/6 mice.
Johansson L; Fotsch C; Bartberger MD; Castro VM; Chen M; Emery M; Gustafsson S; Hale C; Hickman D; Homan E; Jordan SR; Komorowski R; Li A; McRae K; Moniz G; Matsumoto G; Orihuela C; Palm G; Veniant M; Wang M; Williams M; Zhang J
J Med Chem; 2008 May; 51(10):2933-43. PubMed ID: 18419108
[TBL] [Abstract][Full Text] [Related]
15. A novel highly potent and selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, UI-1499.
Byun SY; Shin YJ; Nam KY; Hong SP; Ahn SK
Life Sci; 2015 Jan; 120():1-7. PubMed ID: 25447448
[TBL] [Abstract][Full Text] [Related]
16. Adamantane sulfone and sulfonamide 11-beta-HSD1 Inhibitors.
Sorensen B; Winn M; Rohde J; Shuai Q; Wang J; Fung S; Monzon K; Chiou W; Stolarik D; Imade H; Pan L; Deng X; Chovan L; Longenecker K; Judge R; Qin W; Brune M; Camp H; Frevert EU; Jacobson P; Link JT
Bioorg Med Chem Lett; 2007 Jan; 17(2):527-32. PubMed ID: 17070044
[TBL] [Abstract][Full Text] [Related]
17. Discovery of novel, potent benzamide inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) exhibiting oral activity in an enzyme inhibition ex vivo model.
Julian LD; Wang Z; Bostick T; Caille S; Choi R; DeGraffenreid M; Di Y; He X; Hungate RW; Jaen JC; Liu J; Monshouwer M; McMinn D; Rew Y; Sudom A; Sun D; Tu H; Ursu S; Walker N; Yan X; Ye Q; Powers JP
J Med Chem; 2008 Jul; 51(13):3953-60. PubMed ID: 18553955
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and structure-activity relationship of 2-adamantylmethyl tetrazoles as potent and selective inhibitors of human 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1).
Ye XY; Yoon D; Chen SY; Nayeem A; Golla R; Seethala R; Wang M; Harper T; Sleczka BG; Apedo A; Li YX; He B; Kirby M; Gordon DA; Robl JA
Bioorg Med Chem Lett; 2014 Jan; 24(2):654-60. PubMed ID: 24360604
[TBL] [Abstract][Full Text] [Related]
19. Discovery and optimization of adamantyl carbamate inhibitors of 11β-HSD1.
Tice CM; Zhao W; Krosky PM; Kruk BA; Berbaum J; Johnson JA; Bukhtiyarov Y; Panemangalore R; Scott BB; Zhao Y; Bruno JG; Howard L; Togias J; Ye YJ; Singh SB; McKeever BM; Lindblom PR; Guo J; Guo R; Nar H; Schuler-Metz A; Gregg RE; Leftheris K; Harrison RK; McGeehan GM; Zhuang L; Claremon DA
Bioorg Med Chem Lett; 2010 Nov; 20(22):6725-9. PubMed ID: 20864344
[TBL] [Abstract][Full Text] [Related]
20. Discovery of novel inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 by docking and pharmacophore modeling.
Yang H; Dou W; Lou J; Leng Y; Shen J
Bioorg Med Chem Lett; 2008 Feb; 18(4):1340-5. PubMed ID: 18242087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
